The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.
Open accessAbstract
Activation of the tyrosine kinase of the c-src gene product, pp60c-src, has been shown to occur in nearly every primary colorectal carcinoma, and is found as early as in polyps of high malignant potential. However, no studies have addressed potential pp60c-src changes which occur during progression. To examine this question, we have studied kinase activity and protein levels in 7 colonic polyps, 19 primary lesions, and 19 liver metastases relative to normal colonic mucosa. Significant increases in tyrosine kinase activity were seen as early as in colonic polyps of high malignant potential. Further increases were observed in activity and level in primary tumors. However, the greatest increases in activity and protein levels were observed in liver metastases. Additionally, six metastatic lesions were obtained in which synchronous primary tumor was resected. In each of these liver metastases, pp60c-src activity and level were significantly increased relative to the corresponding primary tumor, as well as to normal colonic mucosa. Our results demonstrate that progression of colon primary tumors to liver metastases correlates with increased pp60c-src kinase activity and protein level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the SRC activation signature score was significantly associated with metastasis and primary tumor stage I-IV progression (Fig. 2g,h), in agreement with previous studies in CRC [37–40].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Talamonti et al reported increased activity and expression of SFKs in progressive stages of human colorectal cancer, suggesting that colon cancer progression may be dependent on increased SFK protein level and subsequent activity (Talamonti et al., 1993).”
From Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab (2011) · cites this paper as Talamonti et al., 1993
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Higher expression and activity of SRC has been documented in primary colon tumors compared with benign polyps or non-transformed colonic mucosa, and increased activity is observed in progressive stages of CRC [23–26].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [25]
In the citing paper
“However, c-Src seems to experience a robust increase in expression and activity in CRC liver metastases compared with metastases derived from other tumors types [11, 12]”
From Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src (2016) · cites this paper as [12]
In the citing paper
“C-src, though, seems to have a robust increase regarding expression and activity in CRC liver metastases compared to those derived from other tumors types.3,11,13”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [11]
In the citing paper
“In CRC cell lines and primary tumors, both c-src kinase activity and protein expression levels have been found elevated compared either to normal colonic mucosal cells and fibroblasts or normal adjacent tissue, respectively.3,10,11”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [11]
In the citing paper
“Increased specific activity and expression levels have been detected in colonic polyps of high malignant potential and severe dysplasia.11,12”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Identification and characterization of the familial adenomatous polyposis coli gene
Groden, J. L., Thliveris, A. T., Samowitz, W. S., Carlson, M. L., Gelbert, L. M., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L. N., Robertson, M. A., et al. (1991) · Cell · doi:10.1016/0092-8674(81)90021-0 · Cited by 2,794
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler‐Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,701
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,331
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,097
Mutations of Chromosome 5q21 Genes in FAP and Colorectal Cancer Patients
Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., et al. (1991) · Science · doi:10.1126/science.1651563 · Cited by 1,891
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., BOOM, J. H. V., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 406
Nakamura, K., Chijiíwa, Y., & Nawata, H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00090-1 · Cited by 12
Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications
Lesslie, D. P., & Gallick, G. E. (2005) · Current Cancer Therapy Reviews · doi:10.2174/1573394052952500 · Cited by 12
Self-citationSmall-Molecule Inhibition of the UNC-Src Interaction Impairs Dynamic Src Localization in Cells
Garivet, G., Hofer, W., Konitsiotis, A. D., Klein, C., Kaiser, N., Mejuch, T., Fansa, E. K., Alsaabi, R., Wittinghofer, A., Bastiaens, P. I. H., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.02.019 · Cited by 11
Bello‐Alvarez, C., Moral‐Morales, A. D., González‐Arenas, A., & Camacho‐Arroyo, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640298 · Cited by 11
Expression and Clinical Significance of FAK and Src Proteins in Human Endometrial Adenocarcinoma
Chatzizacharias, N. A., Giaginis, C., Gatzidou, E. T., Tsourouflis, G. S., Sfiniadakis, I., Alexandrou, P. T., & Theocharis, S. E. (2010) · Pathology & Oncology Research · doi:10.1007/s12253-010-9310-6 · Cited by 11
Wu, W.-G., Wang, Y., Xu, Y.-Z., Liu, Y., & Zhang, H.-Z. (2014) · Placenta · doi:10.1016/j.placenta.2014.07.012 · Cited by 11
Novel Targets for Anticancer Treatment Development in Colorectal Cancer
Macarulla, T. M., Ramos, F. J., Capdevila, J., Saura, C., & Tabernero, J. M. (2006) · Clinical Colorectal Cancer · doi:10.3816/ccc.2006.n.045 · Cited by 11
Alessandro, R., Flugy, A. M., Russo, D., Stassi, G., Leo, A. D., Corrado, C., Alaimo, G., & Leo, G. D. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20236 · Cited by 11
Abe, H., Mochizuki, S., Ohara, K., Ueno, M., Ochiai, H., Kitagawa, Y., Hino, O., Sato, H., & Okada, Y. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.011 · Cited by 10
Ikeuchi, M., Yuki, R., Saito, Y., & Nakayama, Y. (2020) · The FASEB Journal · doi:10.1096/fj.202001909r · Cited by 9
Focal adhesion kinase and Src expression in premalignant and malignant skin lesions
Choi, C. W., Kim, Y. H., Sohn, J. H., Lee, H., & Kim, W. (2015) · Experimental Dermatology · doi:10.1111/exd.12676 · Cited by 10
Structure-activity relationship of a novel peptide substrate for p60c-src protein tyrosine kinase
Lou, Q., Wu, J. J., Salmon, S. E., & Lam, K. S. (1996) · Letters in Peptide Science · doi:10.1007/bf00142241 · Cited by 10
Involvement of Src in the Adaptation of Cancer Cells under Microenvironmental Stresses
Hasan, A., Ijiri, T. W., & Sato, K. (2012) · Journal of Signal Transduction · doi:10.1155/2012/483796 · Cited by 9
Ballesta, A., Lopez, J., Popgeorgiev, N., Gonzalo, P., Doumic, M., & Gillet, G. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003011 · Cited by 9
Bendinelli, P., Maroni, P., Matteucci, E., & Desiderio, M. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.004 · Cited by 9
Singh, S., Singh, S., & Shukla, P. (2010) · Medicinal Chemistry Research · doi:10.1007/s00044-010-9416-0 · Cited by 8
Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin
Indermaur, M. D., Xiong, Y., Kamath, S. G., Boren, T., Hakam, A., Wenham, R. M., Apte, S. M., & Lancaster, J. M. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.003 · Cited by 9
The role of Src family kinases in the normal and neoplastic gastrointestinal tract
Banker, N. A., Evers, B. M., Hellmich, M. R., & Townsend, C. M. (1996) · Surgical Oncology · doi:10.1016/s0960-7404(96)80023-5 · Cited by 8
p53 mutations in sweat gland carcinomas
Biernat, W., Peraud, A., Wozniak, L., & Ohgaki, H. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980504)76:3 · Cited by 40
Jessup, J. M., Steele, G. D., Thomas, P., Summerhayes, I. C., Mercurio, A. M., Andrews, C. W., Chen, L., & Kolodner, R. D. (1994) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30497-6 · Cited by 8
Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer
Rubio-Cuesta, B., Carretero-Puche, C., Llamas, P., Sarmentero, J., Gil-Calderon, B., Lens-Pardo, A., Antón-Pascual, B., Rubio-González, E., Cámara-Jurado, M., Salamanca, J., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03058-6 · Cited by 7
Csk αC Helix: A Computational Analysis of an Essential Region for Conformational Transitions
Dias, R. V. R., Ferreira, C. T. A., Jennings, P. A., Whitford, P. C., & de Oliveira, L. C. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c05408 · Cited by 7
Safari, F., Dogaheh, F. A., & Dadashi, H. (2023) · 3 Biotech · doi:10.1007/s13205-023-03763-0 · Cited by 7
Novel Agents in the Treatment of Metastatic Colorectal Cancer
Leong, S., Messersmith, W. A., Tan, A. C., & Eckhardt, S. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181e076c5 · Cited by 7
Agrez, M., Garg, M. B., Dorahy, D. J., & Ackland, S. P. (2011) · Journal of Cancer Therapy · doi:10.4236/jct.2011.23039 · Cited by 7
Bradley, S. T., Lee, Y., Gürel, Z., & Kimple, R. J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23372 · Cited by 6
Multiplex Analysis of Src Family Kinase Signaling by Microbead Suspension Arrays
Campbell, M., Lie, W., Zhao, J., Hayes, D., Mistry, J., Kung, H.-J., Luciw, P. A., & Khan, I. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0255 · Cited by 6
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Rothschild, S. I., & Gautschi, O. P. (2012) · Clinical Investigation · doi:10.4155/cli.12.27 · Cited by 6
Emerging therapies for colorectal cancer
Hezel, A., & Ryan, D. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.867 · Cited by 6
c-src activating mutation analysis in Chinese patients with colorectal cancer
Tan, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i15.2351 · Cited by 6
Wu, Z.-L., Wang, Y., Jia, X., Wang, Y.-G., & Wang, H. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i5.603 · Cited by 5
Tang, Y.-C., Ou, J., Hsu, S.-C., Huang, C., Lin, L.-M., Chang, H.-H., Wang, Y.-H., Huang, Z.-T., Sun, M., Liu, K.-J., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107556 · Cited by 5
Puvvala, S., Jadhav, V. D., Narkhede, U. C., Farooq, S. M., & Reddy, C. V. (2017) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2912 · Cited by 5
Src is dephosphorylated at tyrosine 530 in human colon carcinomas
Zhu, S., Bjorge, J. D., & Fujita, D. J. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0229-6 · Cited by 5
Wu, J. J., Phan, H. A. T., Salmon, S. E., & Lam, K. S. (1996) · Letters in Peptide Science · doi:10.1007/bf00127665 · Cited by 5
New approaches and targets in advanced colorectal cancer
Macarulla, T. M., Capdevila, J., Pérez-García, J. M., Ramos, F. J., Élez, E., Markman, B., Ruiz-Echarri, M., & Tabernero, J. M. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70019-x · Cited by 4
Linkage Disequilibrium and Haplotype Analysis of Src and Yes1 Genes in Thyroid Cancer
Nisar, A., Mahjabeen, I., Mehmood, A., Ahmed, M. W., Khurshid, K., & Kayani, M. A. (2020) · Future Oncology · doi:10.2217/fon-2019-0690 · Cited by 4
The Role of Oncogene Activation in Tumor Progression
Gray, M. J., & Gallick, G. E. (2010) · Springer eBooks · doi:10.1007/978-90-481-3725-1_2 · Cited by 4
Self-citationBairy, S. K., Suneel Kumar, B. V. S., Bhalla, J. U. T., Pramod, A. B., & Ravikumar, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00789.x · Cited by 4
RITCHIE, S., & Bonham, K. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.391 · Cited by 4
Tiganis, T. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_5 · Cited by 5
Allgayer, H. (2003) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-59349-9_2 · Cited by 4
COX-2 and apoptosis: NSAIDs as effectors of programmed cell death
Simmons, D. L., Madsen, M. L., & Robertson, P. M. (1998) · Springer eBooks · doi:10.1007/978-94-011-4872-6_5 · Cited by 4
The Molecular Biology of Colorectal Carcinoma
Jessup, J. M., Gallick, G. E., & Liu, B. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_13 · Cited by 4
Self-citationMundy, G. R., & Guise, T. A. (1998) · Endocrine Related Cancer · doi:10.1677/erc.0.0050015 · Cited by 4
Src kinase slows collective rotation of confined epithelial cell monolayers
Pricoupenko, N., Marsigliesi, F., Marcq, P., Blanch-Mercader, C., & Bonnet, I. (2024) · Soft Matter · doi:10.1039/d4sm00827h · Cited by 4
Dynamic Regulation of Adherens Junctions: Implication in Cell Differentiation and Tumor Development
Pelissier-Rota, M. A., Chartier, N. T., & Jacquier‐Sarlin, M. R. (2015) · Springer eBooks · doi:10.1007/978-94-017-7380-5_4 · Cited by 3
Kim, S. J., Noh, T. H., Son, S., Kim, D. H., Kim, W., Lee, Y., Choo, J., Heo, G., Kim, M. J., Chung, H. Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0942-x · Cited by 3
Protein Kinases and Protein Phosphatases in Signal Transduction Pathways
Sawyer, T. K. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00070-5 · Cited by 3
Li, B., Xu, L., Shen, Q., Gu, X., & Fu, W. (2013) · Molecular Simulation · doi:10.1080/08927022.2013.809717 · Cited by 3
Lund, S. C., Brábek, J., & Hanks, S. K. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20466 · Cited by 3
Colorectal Cancer: Molecular Staging Models that Charactrize Risk and Enhance Prognosis.
Ahmed, F. (2004) · PubMed · Cited by 3
Uekita, T., Yagi, R., Ichimura, T., & Sakai, R. (2024) · Genes to Cells · doi:10.1111/gtc.13103 · Cited by 2
Olive Leaves and Mill Waste Exert Anti-Tumoral Properties in Hepatoma Cell Line
(2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000170 · Cited by 2
Role of PTPRT in obesity and its substrate paxillin tyrosine-88 in colorectal cancer
Scott, A. J. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
Rühlmann, F., Nietert, M. M., Sprenger, T., Wolff, H. A., Homayounfar, K., Middel, P., Bohnenberger, H., Beißbarth, T., Ghadimi, Β. M., Liersch, T., et al. (2017) · Journal of Cancer · doi:10.7150/jca.16980 · Cited by 2
V-Src delocalizes Aurora B by suppressing Aurora B kinase activity during monopolar cytokinesis.
Ota, R., Watanabe, T., Wazawa, Y., Kuwajima, H., Honda, T., Soeda, S., Saito, Y., Yuki, R., Fukumoto, Y., Yamaguchi, N., et al. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110764 · Cited by 2
Advances in targeted therapies for metastatic colorectal cancer
Pérez-García, J. M., Capdevila, J., Macarulla, T. M., Ramos, F. J., Élez, E., Ruiz-Echarri, M., & Tabernero, J. M. (2009) · Therapy · doi:10.2217/thy.09.11 · Cited by 2
Sawyer, T. K., Bohacek, R. S., Shakespeare, W. C., Metcalf, C. A., Wang, Y., Sundaramoorthi, R., Keenan, T. P., Narula, S. S., & Dalgarno, D. C. (2005) · Springer eBooks · doi:10.1007/0-387-24532-4_11 · Cited by 2
Discovery, Development, and Testing of Substrates and Inhibitors of pp60 C-SRC
Budde, R. J. A., McMurray, J. S., Saya, H., Gallick, G. E., & Levin, V. A. (1995) · Pharmaceutical Biology · doi:10.3109/13880209509067085 · Cited by 2
Self-citationBiology of Colorectal Cancer Liver Metastases
Wray, C. J., Shah, A. N., Berman, R. S., & Ahmad, S. A. (2008) · Springer eBooks · doi:10.1007/978-1-84628-947-7_2 · Cited by 1
Inhibition of the Src Oncogene: Therapeutic Potential in Ovarian Carcinoma
Han, L. Y., & Sood, A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7216-3_5 · Cited by 1
Wen, X.-H., Sun, X., Ou, Z., Jiang, J., Chen, Q., He, X., Hu, Z., Qiao, H., Zhou, K., Li, X., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022148 · Cited by 1
Resistance to dasatinib is associated with the activation of Akt in oral squamous cell carcinoma
Yee, P. S., Gan, C. P., Zainal, N. S., Chiang, I. K., Dionne, K. R., Fadlullah, M. Z. H., Lee, B. K. B., Tiong, K. H., Mun, K. S., Abraham, M. T., et al. (2017) · Translational Research in Oral Oncology · doi:10.1177/2057178x17702920 · Cited by 1
Oncogenes in tumor progression
Himelstein, B. P., & Muschel, R. J. (1995) · Advances in genome biology · doi:10.1016/s1067-5701(06)80004-5 · Cited by 1
Oct3 and Sox2 Expression in Mammary Carcinoma Cells
Soignier, Y. (2010) · eScholarship (California Digital Library) · Cited by 1
Clinical Development of Src Family Kinase Inhibitors in Malignant Melanoma
Macpherson, I. R., Jones, R. J., & Evans, T. R. J. (2007) · The Open Cancer Journal · doi:10.2174/1874079000701010009 · Cited by 1
The expression ofc-srcgene in the carcinogenesis process of human cardia adenocarcinoma
Wang, X.-J. (1999) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i6.488 · Cited by 1
Simmons, D. L., Lu, X., Bradshaw, W. S., & Xie, W. (1996) · Springer eBooks · doi:10.1007/978-94-010-9029-2_3
Dias, M. H. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2012.tde-24052013-093639
Characterization of Jak, STAT, and Src interactions in Head and Neck Squamous Cell Carcinoma
Jaseja, R. (2013) · Digital Commons-TMC (Texas Medical Center)
Sanmartin, C. N. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The role of Src kinase in renal cell carcinoma
Qayyum, T. (2014) · Enlighten: Theses (The University of Glasgow)
Rostaing-Puissant, B., CHAMBAZ, E. M., Romain, S., Spyratos, F., Daver, A., Jourdan, M. L., Descôtes, F., Colonna, M., Martin, P., & Bolla, M. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016157901500
Dissection of α6β4 Integrin-Dependent Signaling and Breast Carcinoma Invasion: A Dissertation
Yang, X. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/k2m9-am39
IAP Regulation of Tumor Metastasis: A Dissertation
Mehrotra, S. (2009) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/2ajg-8646
GROWTH FACTOR AND SIGNAL TRANSDUCTION TARGETS FOR CANCER THERAPY
Leopold, W. R., Bridges, A. J., Decker, S. J., Fry, D. W., Kraker, A. J., & Sebolt, J. S. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50004-8
Src Family Tyrosine Kinases: Implications for Mammary Tumor Progression
Marcotte, R., & Muller, W. J. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_16
Rühlmann, F. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5452
Hogan, J. D. (1999) · University of New Hampshire Scholars Repository (University of New Hampshire at Manchester)
Investigations into the Interaction between Src Kinase and Wnt Signaling
Tang, P. L. (2009) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/14854
Brunton, V. G., Avizienyte, E., Fincham, V. J., Serrels, B., Metcalf, C. A., Sawyer, T. K., & Frame, M. C. (2023) · doi:10.1158/0008-5472.c.6494636
Data from Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53
Zhao, L., Li, W., Marshall, C. M., Griffin, T. W., Hanson, M., Hick, R. W., Dentchev, T., Williams, E. A., Werth, A. J., Miller, C. A., et al. (2023) · doi:10.1158/0008-5472.c.6500072
Data from Differing Src Signaling Levels Have Distinct Outcomes in Drosophila
Vidal, M., Warner, S., Read, R. D., & Cagan, R. L. (2023) · doi:10.1158/0008-5472.c.6496667
Kopetz, S., Lesslie, D. P., Dallas, N. A., Park, S. I., Johnson, M., Parikh, N. U., Kim, M. P., Abbruzzese, J. L., Ellis, L. M., Chandra, J., et al. (2023) · doi:10.1158/0008-5472.c.6499370.v1
Self-citationDemetri, G. D., Russo, P. L., Macpherson, I. R., Wang, D., Morgan, J. A., Brunton, V. G., Paliwal, P., Agrawal, S., Voi, M., & Evans, T. R. J. (2023) · doi:10.1158/1078-0432.c.6517603
Demetri, G. D., Russo, P. L., Macpherson, I. R., Wang, D., Morgan, J. A., Brunton, V. G., Paliwal, P., Agrawal, S., Voi, M., & Evans, T. R. J. (2023) · doi:10.1158/1078-0432.c.6517603.v1
Alavi, M., Safari, F., Asl, S. F., & Mansour‐Ghanaei, F. (2025) · Stem Cells International · doi:10.1155/sci/7434211
Upregulation of EphA2 by Src counteracts Src-induced loss of cell adhesion.
Takada, M., Murata, M., Soeda, S., Honda, T., Yuki, R., & Nakayama, Y. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.114898
Flacelière, M. (2012) · theses.fr (ABES) · doi:10.70675/279c25e4z8fb5z462fz888bz9bae48f71e26
Mécanismes moléculaires d’activation des intégrines par la kindline-2 lors de l’adhésion cellulaire
Orré, T. (2017) · theses.fr (ABES) · doi:10.70675/668527cazb2b3z4927zac3azd4b652c5f733
Metadata
- Authors
- Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Talamonti, M S
- Venue
- Journal of Clinical Investigation
- Published
- 1993-01-01
- Volume
- 91
- Issue
- 1
- Pages
- 53-60
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC329994
- OpenAlex
- W2030565228
- Cited by
- 399
- References
- 45
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 11 · 2022: 6 · 2021: 6 · 2020: 6 · 2019: 6 · 2018: 6 · 2017: 14 · 2016: 8 · 2015: 13 · 2014: 11 · 2013: 17 · 2012: 24
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca053167-06)
- National Cancer Institute (CA09599, CA53167, T32CA009599)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src kinase, tyrosine kinase activity, colorectal cancer, tumor progression, colonic polyps, liver metastasis, synchronous primary tumors, oncogene activation
- MeSH terms
- Adenocarcinoma, Adenoma, Antigen-Antibody Complex, Colonic Neoplasms, Colonic Polyps, Humans, Intestinal Mucosa, Liver Neoplasms, Neoplasm Metastasis, Neoplasm Staging, Phosphopyruvate Hydratase, Phosphorylation, Protein Kinases, Protein-Tyrosine Kinases, Rectal Neoplasms, Reference Values, Immunoblotting, Proto-Oncogene Proteins pp60(c-src)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
